Amended Current Report Filing (8-k/a)
January 18 2022 - 6:29AM
Edgar (US Regulatory)
0001800392
true
0001800392
2021-02-11
2021-02-11
0001800392
vena:OrdinarySharesMember
2021-02-11
2021-02-11
0001800392
vena:RedeemableWarrantsEachWarrantExercisableForOneHalfOrdinaryShareMember
2021-02-11
2021-02-11
0001800392
vena:RightsEachToReceiveOnetenth110OfOneOrdinaryShareMember
2021-02-11
2021-02-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United
States
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 8-K/A
Amendment No. 2 to Current Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
February
11, 2021
Date
of Report (Date of earliest event reported)
Venus Acquisition Corporation
(Exact
Name of Registrant as Specified in its Charter)
Cayman Islands
|
|
001-40024
|
|
n/a 00-0000000
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
477 Madison Avenue, 6th Floor
New York, NY 10022
|
|
n/a
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (917) 267-4568
N/A
(Former
name or former address, if changed since last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Units, each consisting of one ordinary share, one Redeemable Warrant to purchase one-half ordinary share and one right to acquire 1/10 of an ordinary share
|
|
VENAU
|
|
NASDAQ Capital Market
|
Ordinary Shares
|
|
VENA
|
|
NASDAQ Capital Market
|
Redeemable warrants, each warrant exercisable
for one-half ordinary share
|
|
VENAW
|
|
NASDAQ Capital Market
|
Rights, each to receive one-tenth (1/10) of one ordinary share
|
|
VENAR
|
|
NASDAQ Capital Markek
|
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Explanatory
Note
This Amendment No. 2 to the Current Report on
Form 8K/A (this “report”) amends the Current Report on Form 8K/A of Venus Acquisition Corporation for the period ended February
11, 2021, as filed with the Securities and Exchange Commission (“SEC”) on May 17, 2021 (the “Original Report”).
Background of Restatement
On April 12, 2021, the Acting Director of the
Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies(“SPACs”)” (the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that provided for potential changes to the settlement amounts dependent
upon the characteristics of the holder of the warrant, which terms are similar to those contained in the warrant agreement governing the
Company’s warrants. As a result of the SEC Statement, on January 7, 2021, the Company re-evaluated the accounting treatment of the
4,600,000 warrants that were issued to the Company’s public shareholders in a public offering that closed concurrently with the
closing of the Initial Public Offering (the “Public Warrants”). The Company previously accounted for the Public Warrants as
components of liabilities.
As a result of the above, the Company should
have classified the Public Warrants as component of equity in its previously issued financial statements. The Company’s accounting
for the Public Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously
reported operating expenses or cash.
In addition, in accordance with the SEC and its staff’s
guidance on redeemable equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480), paragraph 10-S99, redemption
provisions not solely within the control of the Company require ordinary share subject to redemption to be classified outside of permanent
equity. The Company had previously classified a portion of its ordinary share in permanent equity. Although the Company did not specify
a maximum redemption threshold, its charter provides that currently, the Company will not redeem its public shares in an amount that would
cause its net tangible assets to be less than $5,000,001. On January 7, 2021, the Company determined that the threshold would not change
the nature of the underlying shares as redeemable and thus would be required to be disclosed outside equity. As a result, the Company’s
previously issued (i) audited balance sheet as of February 11, 2021 included in the Company’s Current Report on Form 8-K/A filed
with the SEC on May 17, 2021 should no longer be relied upon, and in each case, should be corrected to classify Public Warrants as equity
and all of the Public Shares as temporary equity.
In connection with the restatement, the Company’s
management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the restatement. As a result
of that reassessment, the Company’s management determined that its disclosure controls and procedures for such periods were not
effective due to a material weakness in internal control over financial reporting related to the complex equity instruments.
The restatement is more fully described in Note
2 of the notes to the financial statements included herein.
Items Amended
in this Form 8-K/A
This report presents the Original Report, amended
and restated with modifications necessary to reflect the restatements, but without any other amendments, modifications or updates. As
such, this report speaks only as of the date the Original Report was filed, and should be read in conjunction with our other SEC filings,
including our SEC filings subsequent to the date of the Original Report.
The following items have been amended to reflect
the restatements:
Part I, Item 9.01. Financial Statements and Exhibits
In addition, the Company’s Chief Executive
Officer and Chief Financial Officer have provided new certifications dated as of the date of this filing in connection with this report
(Exhibits 99.1).
Except as described above, this Amendment No. 2
does not amend, update or change any other items or disclosures in the Original Filing and does not purport to reflect any information
or events subsequent to the filing thereof. As such, this Amendment No. 2 speaks only as of the date the Original Filing was filed,
and we have not undertaken herein to amend, supplement or update any information contained in the Original Filing to give effect to any
subsequent events. Accordingly, this Amendment No. 2 should be read in conjunction with our filings made with the SEC subsequent
to the filing of the Original Filing, including any amendment to those filings.
Item 8.01. Other Events.
As previously disclosed
on a Current Report on Form 8-K dated February 11, 2021, Venus Acquisition Corporation (the “Company”) consummated its initial
public offering (“IPO”) of 4,000,000 units (the “Units”) on February 11, 2021 and the full exercise of the underwriter’s
over-allotment option of 600,000 Units on such date. Each Unit consists of one ordinary share (“Ordinary Share”) and one
warrant (“Warrant”) entitling its holder to purchase one Ordinary Share at a price of $11.50 per whole share. The Units were
sold at an offering price of $10.00 per Unit, generating gross proceeds of $46,000,000.
As of February 11, 2021,
a total of $46,460,000 of the net proceeds from the public offering and the private placement consummated simultaneously with the closing
of the IPO and the over-allotment option were deposited in a trust account established for the benefit of the Company’s public
stockholders.
An audited balance sheet
as of February 11, 2021 reflecting receipt of the proceeds upon consummation of the public offering and the private placement is included
with this report as Exhibit 99.1
Item 9.01. Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: January 14, 2022
Venus
ACQUISITION Corporation
By:
|
/s/
Yanming Liu
|
|
Name:
|
Yanming Liu
|
|
Title:
|
Chief Executive Officer
|
|
MicroAlgo (NASDAQ:MLGO)
Historical Stock Chart
From Jun 2024 to Jul 2024
MicroAlgo (NASDAQ:MLGO)
Historical Stock Chart
From Jul 2023 to Jul 2024